Welcome to the ValueWiki PREMD INC. J (PMD:CA) article! Register for free or click the "edit" link to contribute!

PREMD INC. J (PMD:CA)

From ValueWiki

Jump to: navigation, search

Launch Chat Window

TSX \ Life Sciences \ Biotechnology & Pharmaceuticals

PREMD INC. develops tests that detect the risk of life-threatening diseases at the earliest possible stage when they can be effectively treated, perhaps even prevented. The company's products currently focus on cardiovascular disease and cancer.Summary from Toronto Stock Exchange

1 Company Analysis
2 News Feed
3 Risks
4 Research Links
5 Notes

Today

Max

[edit]

Company Analysis

You can add your own information here - just click the blue edit tab. Or view examples at the Start a new article page.

The edit window has shortcut and help links if you need them.^[1] Be bold!

[edit]

News Feed

12/10/08 9:12 am	PreMD Files Provisional Patent Application Describing a New Method of Quantifying Cancer Biomarkers (PR Newswire)
11/24/08 9:11 am	PreMD Inc. Enters Clinical Study with Cosmetics Conglomerate (CNW Group)
11/13/08 5:11 pm	PreMD Inc. Reports Third Quarter Results and Appoints New Chief Financial Officer (CNW Group)
11/04/08 8:11 am	TSX Delisting Review - PreMD Inc. (PMD) (CNW Group)
11/03/08 4:11 pm	Listing Review initiated by the Toronto Stock Exchange (CNW Group)
10/21/08 8:10 am	Breast Cancer Clinical Data Accepted for Oral Presentation (CNW Group)